April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
Based on market forecasts, the APAC behavioral health sector will expand from USD 19.07 billion in 2024 to USD 56.58 billion by 2034, experiencing a CAGR of 11.49%. The rising prevalence of mental health disorders and technological advancements drive the market....
April 21, 2026
According to market projections, the U.S. healthcare revenue cycle management sector is expected to grow from USD 65.38 billion in 2025 to USD 195.92 billion by 2035, reflecting a CAGR of 11.6%. The U.S. healthcare revenue cycle management market is growing due to rising healthcare investments and chronic conditions....
April 21, 2026
Projections indicate that, Middle East & Africa behavioral health industry is projected to rise from USD 5.2 billion in 2024 to USD 9.99 billion by 2034, reflecting a CAGR of 6.75% over the next decade. The rising prevalence of mental health disorders and technological advancements drive the market. GCC countries dominated due to the increasing...
April 21, 2026
APAC Central Lab Marke (By Service Type: Safety Testing, Specialty Testing & Biomarkers, Genomic & Molecular Testing, Pathology & Histology Services, Microbiology & Virology, Clinical Supply Chain & Biorepository; By Therapeutic Area: Oncology, Infectious Diseases, Cardiovascular & Metabolic Diseases, Neurology & Central...
April 21, 2026
According to market projections, the new chemical entities (NCE) CDMO sector is expected to grow from USD 2.65 billion in 2024 to USD 7.83 billion by 2034, reflecting a CAGR of 11.44%. The new chemical entities (NCE) CDMO market is growing due to its offering hope for managing diseases where existing therapies fall short or are inaccessible. North ...
April 21, 2026
Market insights predict, the North America clinical trials industry is expected to grow from USD 55.48 billion in 2025 to USD 99.10 billion by 2035, driven by a CAGR of 4.50%. A surge in R&D investment and research in academic institutions is fueling the market growth. The United States led the market due to the presence of a strong research en...
April 21, 2026
Market insights predict, the Middle East and Africa clinical trials industry is expected to grow from USD 2.81 billion in 2025 to USD 5.79 billion by 2035, driven by a CAGR of 6.80%. The rising prevalence of chronic and lifestyle diseases such as diabetes, cardiovascular disorders, and cancer increases demand for new drugs and therapies has driven ...
April 21, 2026
Market insights predict the Europe clinical trials industry will increase from USD 11.65 billion in 2025 to USD 21.73 billion by 2035, achieving a CAGR of 4.80%. The Europe clinical trials market is expanding due to stringent regulations as well as growing innovations....
April 21, 2026
Market insights predict, the Latin America clinical trials industry is expected to grow from USD 4.67 billion in 2025 to USD 9.17 billion by 2035, driven by a CAGR of 6.30%%. The tremendous advantages of clinical research for pharmaceutical and biotechnology companies in meeting public health needs drive the need for clinical trials. Latin America ...
April 21, 2026
Market insights predict the APAC clinical trials industry will increase from USD 18.87 billion in 2025 to USD 41.33 billion by 2035, achieving a CAGR of 7.16%. The market is growing due to the increasing demand for new and effective therapies and rising R&D investments. In the Asia Pacific region, rapid growth is driven by lower operational cos...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com